SPOTLIGHT -
News
Article
Author(s):
Here’s a look back at selections from our March content series on mood disorders.
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Mount Sinai Researchers Uncover a Promising New Way to Modulate Brain Cell Activity to Potentially Treat Major Depressive Disorder in Adults
Blue Light Blockers: A Behavior Therapy for Mania
Functional vs Structural Cortical Deficit Pattern Biomarkers for Major Depressive Disorder
Treating ‘Morally Objectionable’ Patients
NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)
The Overlap in Sleep Problems and Psychiatric Disorders